Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 290.31 | 310.89 | 289.43 | 235.10 |
| Cost Of Revenue | 85.40 | 77.80 | 72.72 | 57.47 |
| Gross Profit | 204.91 | 233.09 | 216.71 | 177.63 |
| Operating Expense | 219.97 | 234.99 | 223.87 | 198.07 |
| Operating Income | -15.06 | -1.90 | -7.15 | -20.44 |
| EBITDA | 20.50 | 43.36 | 38.29 | 17.92 |
| EBIT | -15.06 | -1.90 | -7.15 | -20.44 |
| Pretax Income | -23.62 | -2.52 | -27.29 | -26.70 |
| Tax Provision | -5.83 | 16.87 | 1.40 | 1.94 |
| Net Income | -17.78 | -19.39 | -28.69 | -28.64 |
| Net Income Common Stockholders | -17.78 | -19.39 | -28.69 | -28.64 |
| Total Expenses | 305.37 | 312.79 | 296.58 | 255.54 |
| Interest Expense | -1.93 | 0 | 0 | 0 |
| Interest Income | 0 | 4.86 | 4.90 | 2.94 |
| Research And Development | 63.31 | 70.30 | 67.68 | 58.38 |
| Selling General And Administration | 121.09 | 119.43 | 110.74 | 101.33 |
| Normalized EBITDA | 32.47 | 49.34 | 63.23 | 26.21 |
| Normalized Income | -8.76 | -14.66 | -8.99 | -22.09 |
| Basic EPS | -0.14 | -0.15 | -0.22 | -0.23 |
| Diluted EPS | -0.14 | -0.15 | -0.22 | -0.23 |
| Tax Effect Of Unusual Items | -2.95 | -1.26 | -5.24 | -1.74 |
| Tax Rate For Calcs | 0.25 | 0.21 | 0.21 | 0.21 |
| Total Unusual Items | -11.97 | -5.99 | -24.94 | -8.29 |
| Total Unusual Items Excluding Goodwill | -11.97 | -5.99 | -24.94 | -8.29 |
| Net Income From Continuing Operation Net Minority Interest | -17.78 | -19.39 | -28.69 | -28.64 |
| Reconciled Depreciation | 35.56 | 45.26 | 45.44 | 38.36 |
| Reconciled Cost Of Revenue | 85.40 | 77.80 | 72.72 | 57.47 |
| Net Interest Income | 1.93 | 4.86 | 4.90 | 2.94 |
| Net Income From Continuing And Discontinued Operation | -17.78 | -19.39 | -28.69 | -28.64 |
| Total Operating Income As Reported | -28.08 | -10.49 | -32.86 | -23.92 |
| Diluted Average Shares | 128.35 | 132.98 | 129.44 | 125.68 |
| Basic Average Shares | 128.35 | 132.98 | 129.44 | 125.68 |
| Diluted NI Availto Com Stockholders | -17.78 | -19.39 | -28.69 | -28.64 |
| Average Dilution Earnings | 0 | 0 | 0 | 0 |
| Net Income Including Noncontrolling Interests | -17.78 | -19.39 | -28.69 | -28.64 |
| Net Income Continuous Operations | -17.78 | -19.39 | -28.69 | -28.64 |
| Other Income Expense | -10.48 | -5.47 | -25.04 | -9.20 |
| Other Non Operating Income Expenses | 1.49 | 0.51 | -0.10 | -0.91 |
| Special Income Charges | -13.02 | -8.58 | -25.80 | -8.45 |
| Restructuring And Mergern Acquisition | 13.02 | 8.58 | 25.80 | 8.45 |
| Gain On Sale Of Security | 1.05 | 2.60 | 0.86 | 0.16 |
| Net Non Operating Interest Income Expense | 1.93 | 4.86 | 4.90 | 2.94 |
| Total Other Finance Cost | -1.93 | -4.86 | 0 | 0 |
| Interest Expense Non Operating | -1.93 | 0 | 0 | 0 |
| Interest Income Non Operating | 0 | 4.86 | 4.90 | 2.94 |
| Depreciation Amortization Depletion Income Statement | 35.56 | 45.26 | 45.44 | 38.36 |
| Depreciation And Amortization In Income Statement | 35.56 | 45.26 | 45.44 | 38.36 |
| Selling And Marketing Expense | 80.82 | 74.36 | 64.62 | 55.48 |
| General And Administrative Expense | 40.27 | 45.07 | 46.12 | 45.86 |
| Other Gand A | 40.27 | 45.07 | 46.12 | 45.86 |
| Operating Revenue | 283.46 | 306.17 | 289.13 | 235.07 |
